rethinkPeptides Search
Menu
Study breakdown

Brain Peptide Derivative Disrupts Dangerous Multi-Species Biofilms on Medical Device Materials

evidence
The takeaway

A kyotorphin peptide conjugated with ibuprofen effectively disrupted multi-species bacterial and fungal biofilms on both polymeric and metallic medical device surfaces.

Multi-species biofilm disruption

IbKTP-NH2 effectively disrupted biofilms containing Candida, Pseudomonas, and Streptococcus simultaneously on both plastic and metal surfaces

What the researchers found

IbKTP-NH2 was tested against multispecies biofilms containing C. albicans, P. aeruginosa, and S. pneumoniae on polymeric and metallic medical device materials:

- Minimum biofilm inhibitory concentrations (MBIC) ranged from 46.5 to 1 mM for bacterial strains

- SEM analysis showed significant biofilm disruption: reduced extracellular matrix production, decreased cell density, and altered cell morphology

- Effective on both polymeric and metallic surfaces relevant to medical devices

- Demonstrated potential antivirulence properties beyond direct antimicrobial killing

The peptide's dual origin — combining a neuropeptide (kyotorphin) with an anti-inflammatory (ibuprofen) — provides both antimicrobial and potentially anti-inflammatory activity.

Why it matters

Healthcare-associated infections from biofilms on medical devices cause significant illness and death worldwide. Multi-species biofilms are especially dangerous because they're more resistant than single-species infections. A peptide-based approach that can disrupt these complex communities on device surfaces could prevent infections before they start.

How the study worked

Multispecies biofilms of C. albicans, P. aeruginosa, and S. pneumoniae were cultured on polymeric and metallic materials mimicking medical device surfaces. Antimicrobial susceptibility testing determined minimum biofilm inhibitory concentrations (MBIC). Scanning electron microscopy (SEM) analyzed biofilm architecture including extracellular matrix, cell density, and morphology after treatment.

What this study cannot tell us

The MBIC values (up to 46.5 mM) are relatively high, which may limit clinical applicability due to required concentrations. Testing was in vitro only — no animal or human studies were conducted. Long-term stability of the peptide on device surfaces was not assessed. The specificity of action and potential for cytotoxicity to human cells were not reported in the abstract.

How to read the evidence

This is an in vitro study testing peptide efficacy against biofilms on materials. While SEM confirmation provides strong visual evidence of biofilm disruption, no in vivo or clinical data exists for this application.

When this study was published

Published in 2025, this study represents current work in developing peptide-based strategies against medical device-associated infections.

The bigger picture

This study repurposes a brain-derived peptide (kyotorphin, originally studied for pain relief) as an antimicrobial agent — an example of how peptides can be redesigned for entirely new applications. The ibuprofen conjugation adds anti-inflammatory properties, addressing both infection and the inflammation it causes in a single molecule.

Questions still open

  • Could IbKTP-NH2 be used as a coating on medical devices to prevent biofilm formation?
  • Are the required concentrations achievable and safe in clinical settings?
  • Does the ibuprofen component contribute to the antimicrobial effect or primarily to anti-inflammatory activity?

Common questions

What is kyotorphin and why use it as an antimicrobial?
Kyotorphin is a naturally occurring dipeptide found in the brain, originally discovered for its pain-relieving properties. Researchers modified it by attaching ibuprofen (IbKTP-NH2) and discovered the conjugate has antimicrobial properties — an example of repurposing bioactive peptides for entirely new medical applications.
Why are biofilms on medical devices so dangerous?
When bacteria and fungi form biofilms on implants, catheters, or prosthetics, they create a protective shield that makes them up to 1,000 times more resistant to antibiotics. Multi-species biofilms (multiple pathogen types together) are even harder to treat. This is why finding new approaches like peptide-based disruption is so important.

Read the original research

Unleashing IbKTP-NH2, a kyotorphin derivative, against bacterial and fungal multispecies biofilm adhesion and viability on materials.

Journal of applied microbiology, 136(9)

Citation

Conceição, Katia; de Andrade, Vitor M; de Oliveira, Vitor D M; Ramu, Vasanthakumar G; Heras, Montserrat; Bardaji, Eduard R; Castanho, Miguel A R B; Capella, Aline G. (2025). Unleashing IbKTP-NH2, a kyotorphin derivative, against bacterial and fungal multispecies biofilm adhesion and viability on materials.. Journal of applied microbiology, 136(9). https://doi.org/10.1093/jambio/lxaf205